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Abstract
Although much is known about signal transduction downstream of insulin-like growth factor-1
(IGF-1), relatively little is known about the global changes in protein expression induced by this
hormone. In this study, the acute effects of IGF-1 on the proteome of murine C2C12 cells were
examined. Cells were treated with IGF-1 for up to 24 hours, lysed, and fractionated into cytosolic,
nuclear, and insoluble portions. Proteins from the cytosolic fraction were further separated using
a new batch ion-exchange chromatography method to reduce sample complexity, followed by two-
dimensional (2D) electrophoresis, and identification of selected proteins by mass spectrometry.
PDQuest software was utilized to identify and catalogue temporal changes in protein expression
during IGF-1 stimulation. In response to IGF-1 stimulation, expression of 23 proteins increased at
least three-fold and expression of 17 proteins decreased at least three-fold compared with control
un-stimulated C2C12 cells. Changes in expression of selected proteins from each group, including
Rho-GDI, cofillin, RAD50, enolase, IκB kinase b (IκBKb) and Hsp70 were confirmed by Western
blotting. Additionally, the position of 136 'landmark' proteins whose expression levels and
physicochemical properties did not change appreciably or consistently during IGF-1 treatment
were mapped and identified. This characterization of large-scale changes in protein expression in
response to growth factor stimulation of C2C12 cells will further help to establish a comprehensive
understanding of the networks and pathways involved in the action of IGF-1.
Introduction
The growth factor IGF-1 is one of the major components
of the mammalian hypothalamic-pituitary growth axis.
Isomers of IGF constitute the principal effector molecules
that regulate the body-wide action of growth hormone by
inducing the proliferation, growth, cell turnover and func-
tion of many tissues, including skeletal muscle [1]. IGF-1
represents one of several alternatively spliced products of
the  igf-1  gene and plays important roles in numerous
aspects of the proliferation and growth of many tissues [2-
4]. The hypertrophic effects of IGF-1 in murine skeletal
muscle result from increased protein synthesis in existing
myofibers combined with an activation of growth and dif-
ferentiation of muscle satellite cells. These findings have
led to studies examining the molecular effects of IGF-1
treatment, including potential protective and regenerative
effects of exogenous IGF-1 in a variety of animal models
of degenerative musculoskeletal diseases and defects,
including Duchenne's muscular dystrophy and age-
related muscle degeneration, cancer models, and lym-
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phocyte activation [5-8]. These studies have demonstrated
that treatment of cells with functional IGF-1 protein or
transduction of mouse or rat skeletal muscle cells with
vectors encoding IGF-1 induces pleiotrophic effects in
many cellular pathways that result in muscle hypertrophy,
enhanced muscle contractility and protection from age-
related muscle wasting.
Global gene expression studies in a variety of target tissues
have identified a number of genes that are either up- or
down-regulated by IGF-1 [9-13]. Particularly in the case of
IGF-1-induced up-regulation, genes identified include
those with mitogenic and differentiation functions, such
as mitogen-actvated protein kinase (MAPK) and phos-
phatidylinositol 3-OH kinase (PI3K) signaling pathways
[14], a variety of muscle functions, intracellular signaling,
cell cycle, transcriptional and translational functions, cel-
lular respiration, and mitochondrial functions [15]. We
have recently examined the effects of IGF-1 on global gene
expression in cultured murine C2C12 myoblasts and have
identified families of genes whose expression is up- or
down-regulated by exposure to IGF-1 for up to 4 hours
[16]. These aberrantly-expressed genes fall into a variety of
functional families, with the most impressive changes
occurring in genes related to steroid biogenesis and fatty
acid metabolism.
We have previously used a microarray-based approach to
identify changes in expression of genes sets in C2C12 cells
in response to IGF-1 treatment. To determine if these tran-
scriptional effects are reflected in alterations of the
encoded proteins, we have now examined the effect of
IGF-1 on the proteome of C2C12 cells using two-dimen-
sional (2D) electrophoresis and mass spectrometry. In
contrast to extensive transcriptional profiling studies of
IGF-1 effects, there is very little information available on
the proteomic consequences of these transcriptional
effects of IGF-1 or of possible biochemical and metabolic
changes in IGF-1-treated cells or tissues. It is therefore not
yet understood how IGF-1-induced transcriptional
changes affect the functions of the gene products and the
complex systems effects of IGF-1 or other growth factors.
In the present study we have characterized the functional
effects of IGF-1 on the cellular proteome and describe in
this report the acute response of murine C2C12 skeletal
muscle myoblasts to IGF-1. We have carried out an exten-
sive analysis of the proteomes of cultured murine myob-
last C2C12 cells exposed acutely to high levels of IGF-1,
and identify by mass spectrometry 23 proteins with
increased expression, 17 proteins with decreased expres-
sion and 136 proteins whose expression was unchanged
after treatment of C2C12 cells with IGF-1. Furthermore,
we used Western blotting methods to confirm altered lev-
els of a set of the most significantly changed proteins dur-
ing the 24 hour incubation period. Among the interesting
protein changes were increased expression of RAD50,
enolase, IκBKb, and Hsp70 and decreased levels of cofilin
and Rho-GDI.
Materials and methods
Reagents
IGF-1 was purchased from Invitrogen (Carlsbad, CA). All
other materials were reagent grade. Antibodies to Rad50,
enolase, IκBKb and RhoGDI were from Santa Cruz Bio-
technology (Santa Cruz, CA) and the Hsp70 antibody was
from BD Biosciences (San Jose, CA). The cofilin antibody
was a generous gift from Dr. Gary Bokoch.
Cell Culture
C2C12 cells were maintained in Dulbecco's modified
Eagle's medium containing high glucose (DMEM; Invitro-
gen) with 10% heat-inactivated fetal bovine serum
(Omega Scientific Inc., Tarzana, CA). For these studies,
cells (seeded at 1.2 × 106 cells/10-cm dish) were grown to
70–80% confluence, transferred to serum-free media for
18 h, and treated for 1, 2, 4, or 8 hours with IGF-1 at a
final concentration of 100 μM IGF-1.
Cell Fractionation
Control or IGF-1-stimulated cells were washed three times
in PBS, and re-suspended in 0.25 ml Lysis Buffer A (20
mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 1.5 mM
μM phenylmethylsulfonyl fluoride (PMSF), 1 mM vanad-
ate, 40 μg/ml leupeptin, and 1 μM MgCl2, 300 microcys-
tin) at 4°C. After 30 min, Triton X-100 was added to a
final concentration of 0.5% (v/v). Samples were centri-
fuged at 13,000 × g for 5 min at 4°C, and the resulting
supernatant-containing soluble cytoplasmic and mem-
brane proteins was removed. The pellet was re-suspended
in 0.1 ml Lysis Buffer B (20 mM HEPES, pH 7.9, 420 mM
NaCl, 0.1 mM EDTA, 1.5 mM MgCl2, and 25% glycerol
containing 300 μM PMSF, 1 mM vanadate, 40 μg/ml leu-
peptin, 1 μM microcystin, and 150 U DNase 1) at 4°C and
sonicated (Branson bath sonicator, Danbury, CT). Again,
the lysates were centrifuged at 13,000 × g for 5 min at 4°C,
and the resulting supernatant-containing proteins from
the nucleus and other membrane-bound organelles was
stored at -80°C for future studies. The detergent-insoluble
pellet was re-suspended in 0.1 ml Lysis Buffer C (5 M urea,
2 M thiourea, 2% CHAPS, 2% SB-3, 40 mM Tris, pH 7.5,
10% glycerol, 150 IU/ml aprotinin, 2 μg/ml leupeptin,
and 1 mM PMSF).
Batch Ion-Exchange, de-salting, and concentration
Cytoplasmic proteins were further batch separated into
four fractions by adsorption onto slurries of Q Sepharose
High Performance beads (GE Healthcare, Chalfont St.
Giles, United Kingdom). A 1:1 slurry of beads was washed
twice in an excess of Binding Buffer (50 mM Tris, pH 7.5,
1 mM EDTA, 1 mM DTT, and 5 mM MgCl2) and centri-Proteome Science 2009, 7:28 http://www.proteomesci.com/content/7/1/28
Page 3 of 18
(page number not for citation purposes)
fuged at 1,700 × g for 2 min. Approximately, 0.5 ml of
C2C12 cytoplasmic proteins (3–4 μg/μl) was added to the
washed beads and mixed at 4°C for 5 min. The beads were
pelleted by gentle centrifugation at 1,700 × g for 2 min,
and the resulting supernatant (Flow Through, FT) was
removed. The beads were re-suspended in Binding Buffer
containing 200 mM NaCl, mixed at 4°C for 5 min, and
the beads were pelleted by centrifugation at 1,700 × g for
2 min. The resulting supernatant (200 mM fraction) was
removed. The beads were re-suspended in Binding Buffer
containing 400 mM NaCl, mixed at 4°C for 5 min, and
the beads were pelleted by centrifugation at 1,700 × g for
2 min. The resulting supernatant (400 mM fraction) was
removed. An identical elution of proteins was performed
in the presence of 650 mM NaCl, followed by a final elu-
tion of 1 M NaCl that yielded very few proteins. A large
majority of proteins observed in the 1 M elution were
found in the 650 mM elution. Therefore, the 1 M elution
fractions were omitted from further analysis. Samples
were desalted and concentrated using a chloroform/meth-
anol precipitation [17] followed by re-suspension in 0.2
ml 9 M Urea/4% CHAPS. Subsequently, Bradford assays
(Pierce, Rockford, IL.) were performed to determine the
new protein concentration.
Two-dimensional electrophoresis
Samples containing 75–200 μg of fractionated cytoplas-
mic proteins were diluted in 2D electrophoresis buffer (2
M thiourea, 5 M urea, 0.25% CHAPS, 0.25% Tween-20,
0.25% SB-3, 10% isopropanol, and 12.5% water-satu-
rated butanol) containing 15 mg DTT and 0.5%
ampholytes (pI ranges 3–10 or 5–8; Bio-Rad; Hercules,
CA) to a final volume of 0.2 ml, and passively absorbed
onto immobilized pH gradient strips (pI ranges 5–8 or 3–
10 NL (non-linear); Bio-Rad) for 4 hours at 20°C fol-
lowed by active rehydration (50 V at 20°C) for 8 hours.
Isoelectric focusing was performed for 35,000 V-h on a
Protean IEF System (Bio-Rad), electrophoresis with the
Criterion gel system (Bio-Rad). 2D gels were stained with
colloidal Coomassie or silver and imaged on a VersaDoc
4000 (Bio-Rad).
Analysis and quantification
Gels were analyzed using the PDQuest software version
7.4.0 (Bio-Rad). Selected spots from individual gel images
were first matched to at least two other replicate gels at
each time point using the 'classic gel match' algorithm
function. Refined maps for individual time points were
created through use of landmarking and manual match-
ing. Once a master gel was created for each time point,
higher analysis set matching was performed to identify
qualitative changes. Quantitative changes were deter-
mined by normalization followed by matching triplicate
samples from individual time points to other time points.
For each analysis, the 2D gel from the unstimulated
C2C12 sample was set as the standard. Based on these set-
tings, 'Analysis Sets' for each of the individual time points
was created for a representative gel using the normalized
parameters to identify qualitative changes and a 2-fold
increase/decrease to identify quantitative changes. Subse-
quently, proteins that consistently displayed a 3-fold or
greater increase or decrease in expression in the cytosol
over three separate experiments were validated and
reported.
MALDI-TOF
Spots containing proteins of interest were excised into 96
well plates using an integrated ExQuest spot cutter (Bio-
Rad). Spots were washed three times in 50% acetonitrile/
10 mM NH4HCO3 followed by a brief dehydration in
100% acetonitrile. Proteins were incubated overnight in
10% acetonitrile/10 mM NH4HCO3 with 0.05 μg trypsin
(Roche; Indianapolis, IN). Isolated peptides were washed
and concentrated in C18 ZipTips (Millipore; Billerica, MA)
according to the manufacturer's protocol. Samples were
directly eluted onto a 100 spot platform using a buffer
containing 4-alpha hydroxy cinnamic acid (Agilent; Santa
Clara, CA), 50% acetonitrile, 10 mM diammonium cit-
rate, and 0.1% trifluoroacetic acid. MALDI-TOF and sub-
sequent MS/MS analysis of specific peptides was
performed on an Applied Biosystems Q-Star XL hybrid
mass spectrometer. MALDI-TOF fingerprint data was ana-
lyzed with the online database at Rockefeller University
http://prowl.rockefeller.edu.
Results
1. Fractionation of cytoplasmic proteins decreases 2D map 
complexity and increases the total number of visualized 
proteins
The serum-depleted C2C12 cells were treated with a single
treatment of IGF-1 designed to mimic a therapeutic dose
as described in Materials and Methods, fractionated into
cytosolic (C), nuclear (N), and detergent-insoluble (I)
fractions, and the expression profile was analyzed. These
early time points were chosen to identify the most robust
and reproducible acute effects of IGF-1 and to avoid the
likely multiple genetic and metabolic effects of enhanced
cell growth, replication, and differentiation. In control
experiments, cells that remained in low serum for the 24
hour IGF-1 treatment did not show significant differences
in protein expression from cells isolated at the beginning
of the treatment, indicating that the potential effects of
C2C12 differentiation were minimal. Our initial findings
from gene expression studies, identified marked effects of
IGF-1 on major steroid and fatty acid pathways, suggest-
ing that prolonged effects seen after long term IGF-1 expo-
sure may result from complex interactions between
multiple genetic, proteomic and metabolic pathways that
will be difficult to interpret at later times. Although all
three fractions showed numerous changes in proteinProteome Science 2009, 7:28 http://www.proteomesci.com/content/7/1/28
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expression, we report here the alerations only in soluble
proteins. To facilitate analysis of the protein mixtures, par-
ticularly the components of the nuclear and detergent-
insoluble fractions, we have used a new protein fractiona-
tion method (Methods and Materials). Protein recovery
after batch ion-exchange and desalt/concentration was
greater than 95% as measured by BCA assay (data not pre-
sented). To test the possibility of selective protein deple-
tion of subclasses of proteins, SDS-PAGE followed by
silver staining and quantitation by Quantity One (Bio-
Rad) was used to examine C2C12 cytoplasmic proteins
before and after protein desalting and concentration
(Additional File 1). The general protein patterns of sam-
ples before and after were very similar, suggesting that lit-
tle significant selective protein losses had occurred under
our experimental conditions. These data indicate that
batch ion-exchange of cytoplasmic proteins provides a
reproducible method to simplify sample preparation for
2D electrophoresis analysis of complex protein mixtures.
2. Generation of a protein expression profile of soluble 
proteins from C2C12 cells
After prolonged (24 hour) incubation with IGF-1, many
C2C12 cells displayed dramatic changes in morphology
and became detached from the cell culture dish, suggest-
ing a major degree of cell loss and death through still
uncharacterized mechanisms. Cells at this stage were not
included in the subsequent analysis. Protein expression
was normalized to the total number of valid spots in each
gel using PDQuest and composite expression maps were
generated for cytosolic proteins eluted with 0, 200, 400, or
650 mM NaCl.
As shown in Figure 1, approximately 700 to 1300 distinct
spots were visualized on gels of each fraction, with an
average of 850 spots per gel. The results from analysis
study provide a molecular fingerprint of the positional
location of proteins expressed in C2C12 cells. One hun-
dred and thirty-six spots were selected from the 0 mM elu-
tion, 200 mM elution, 400 mM elution, and 650 mM
elution of soluble C2C12 lysates excised, prepared for
mass spectrometry, and analyzed on a Q-Star XL-hybrid
mass spectrometer (Applied Biosystems) using MALDI-
TOF as described in Methods. Approximately 4% of all
visualized proteins from the combined supernatant gels
were initially used to create the expression profile and are
listed in Table S1; Additional File 2. The proteins are
divided into their corresponding functional classes. Addi-
tional Files 3, 4, 5, and 6 show the position of all proteins
identified in this study. Table S2; Additional File 7 pro-
vides all MALDI TOF data generated for each protein.
PDQuest was used to determine whether a population of
the identified landmark proteins remained constant
throughout each experiment. Fifty two proteins that were
Batch Ion-Exchange of soluble C2C12 proteins increases the total number of spots visualized 2.5-fold Figure 1
Batch Ion-Exchange of soluble C2C12 proteins increases the total number of spots visualized 2.5-fold. Serum-
starved C2C12 cells were stimulated for 2 hours with 100 nM IGF-1 and lysed in detergent-free buffer to generate soluble pro-
teins. 100 ug of protein was separated by 2D electrophoresis followed by silver staining (left). Another 100 ug of protein was 
further fractionated by batch ion-exchange followed by desalting/concentration [17] before 2D electrophoresis and silver stain-
ing. The total amount of protein detected was analyzed using PDQuest software (Bio-Rad).
No prefractionation
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significantly isolated from other proteins on 2D gels were
selected and total and normalized values for the protein
were compared to each other in three replicate experi-
ments. In each case, the variance of each landmark protein
did not change relative to itself or the total normalized
value of all valid spots within the dataset. Taken together,
these results indicate that the landmark proteins did not
change relative to treatment with IGF-1 in triplicate sam-
ples.
To identify proteins whose expression was up- or down-
regulated by IGF-1 treatment, triplicate samples of cyto-
plasmic proteins from duplicate preparations of serum-
starved C2C12 cells incubated with IGF-1 for 0, 1, 2, 4, or
8 hours and fractionated proteins were separated by 2D
electrophoresis and visualized by silver staining. To con-
firm effective IGF-1 stimulation, C2C12 cell lysates were
probed for activation of signaling proteins downstream of
the IGF-1 receptor that are known to be activated by IGF-
1 (Figure 2). In serum-deprived cells, activation of both
MAPK and Akt were effectively suppressed, as determined
by Western blotting for phospho-Erk and phospho-Akt
473. Upon incubation with IGF-1, cells become activated
and display increased Erk and Akt phosphorylation. The
degree of phosphorylation is sustained over 8 hours and
then both Erk and Akt phosphorylation decrease by 24
hours.
Figure 3 demonstrates that IGF-1 treatment of C2C12 cells
induced numerous changes in protein expression in each
of the four fractions. To illustrate such changes, the data
from the 200 mM NaCl elution of proteins in the cyto-
plasmic fraction of C2C12 cells are shown. Overall, the
amounts of most of the observed proteins did not change
after IGF-1 treatment of C2C12 cells. A minority of pro-
teins demonstrate increases or decreases. PDQuest analy-
sis of selected spots followed by generation of mass
spectrometric data allowed us to identify proteins that
were quantitatively increased (Table 1) or decreased
(Table 2) after IGF-1 stimulation for each of the four elu-
tion conditions. Figure 3 represents a magnified region of
two different sections of 2D gels at each of the 5 time
points and demonstrates the most frequently observed
types of changes in protein expression analyzed in these
studies. In the top panels (yellow circles), expression of an
unidentified protein appears after 1 hour and is sustained
for 8 hours after IGF-1 treatment. In the bottom panels,
expression of an unidentified protein decreases after IGF-
1 treatment (red circle). Additionally in these panels,
shifts in both the intensity and localization of a group of
proteins are observed (blue arrows). Each of these spots
was identified as the molecular chaperone Mot66. During
the time course of the experiment, the intensity of the
individual spots changes with one spot appearing after 2
hours with IGF-1 (marked with an arrow). The observed
shifts in position of proteins could represent splice vari-
ants and/or posttranslational modifications rather than
increases or decreases in absolute amounts of proteins
These changes represent a significant challenge to the
analysis and interpretation of the data (see discussion).
Figure 4A shows changes in protein expression of four
selected proteins from different regions of 2D gels from
the 200 mM NaCl elution. Western blot analysis of Rho-
GDI, cofilin, and PDGF receptor α from cell extracts from
IGF-1-stimulated cells (Figure 4B, top panels) confirm the
decreased expression after IGF-1 treatment identified
from the mass spectroscopic analysis. As a control, West-
ern blots for two proteins whose expression remained
constant during the 8 hour IGF-1 treatment (actin and
Hsp27) are shown (Figure 4B, bottom panels). When
quantified, data from western blots indicate Rho-GDI
expression levels decrease 5.1-fold, cofilin levels drop 8.3-
fold, and PDGF receptor α levels decrease by 4-fold over
the 8 hour time course. These observed decreases in pro-
tein expression are similar to those observed in the 2D
gels. Averaged analysis of the spots on the 2D gels indi-
cates a 4.3-fold decrease for Rho-GDI, a 6-fold decrease
for cofilin, and a 4-fold decrease for PDGF receptor α. Fig-
ure 5A shows regions of 2D gels in which expression of
other proteins including Rad50, enolase, IκBKb, and
Hsp70 increased after treatment with IGF-1. Western blots
for these proteins confirmed the change in expression
IGF-1 treatment of C2C12 cells activates MAP kinase and PI  3-kinase signaling pathways Figure 2
IGF-1 treatment of C2C12 cells activates MAP kinase 
and PI 3-kinase signaling pathways. C2C12 cells were 
serum-starved for 18 hours prior to stimulation with IGF-1 
(100 nM) for 0, 1, 2, 4, 8, or 24 hours. Cells were lysed in 
detergent containing buffer and 20 ug of protein from each 
time point was separated on a 10% SDS polyacrylamide gel. 
Western blots were performed using phosphospecific anti-
bodies to Erk (p42/p44) and Akt (p473) as well as antibodies 
that detect total protein. Actin is shown as a loading control.
0h   1h    2h    4h    8h    24h  
Phospho-p42/44
Erk 2
Phospho-Akt 473
Akt
Actin
50
50
50
50
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(Figure 5B) when compared with actin and Hsp27 expres-
sion (Figure 4B). Rad50 levels increased 2.6 fold, enolase
increased 3.2 fold, IκBKb levels increased 3.8 fold, and
Hsp70 levels increased 2.3 fold. Again, the fold increase as
determined by Western blotting was similar to levels
measured by PDQuest on the 2D gels with Rad50 and
Hsp70 increasing 2-fold and enolase and IκBKb increas-
ing almost 4-fold.
RAD50 is primarily a nuclear protein and its appearance
in the cytosolic fraction of C2C12 cells suggested a
number of possibilities could be happening in cells
including nuclear lysis, cells undergoing apoptosis/necro-
sis, or possibly degradation of the protein. To determine
whether more RAD50 was in the cytosolic fraction after
IGF-1 treatment, Western blot analysis was performed on
whole cell lysates, nuclear fractions, and cytosolic frac-
tions (Figure 5C). In the absence of stimulus, there was a
small, but reproducible amount of RAD50 in the cytosol.
After 8 hours with IGF-1, the amount of RAD50 in the
cytosol had dramatically increased. The total amount of
the protein detected by Western blot did not appreciably
change, indicating that IGF-1 treatment induced a redistri-
bution of RAD50 from the nuclear fraction to the
cytosolic fraction. The significance of RAD50 redistribu-
tion is addressed in the Discussion.
In addition to these stable alterations of protein expres-
sion, our analysis also identified 92 proteins that demon-
strated significant but transient and in some cases multi-
phasic changes in expression after IGF-1 treatment. One
example of this complex kind of changed protein expres-
sion is shown in Figure 6 for the transcription factor eIF-
4H. At early times up to 2 hours after IGF-1 treatment, the
level of eIF-4H protein increases, but then falls over the
following 4 hours. The mechanisms responsible for such
complex regulation will be important to clarify in subse-
quent phases of this study.
Discussion
In these studies, we report initial results of a comprehen-
sive study of the effects of IGF-1 on the proteome of
Analysis of protein expression changes during IGF-1 stimulation Figure 3
Analysis of protein expression changes during IGF-1 stimulation. A) Visualization of significant and reproducible 
changes in protein expression in IGF-treated C2C12 analyzed as above. (Top panel) Expression of proteins highlighted by a yel-
low circles increase after an 8 hour treatment with IGF-1. (Bottom panel) Proteins with red circles are ones that disappear after 
8 hour IGF-1 treatment, while proteins within the blue arrows shift position in response to IGF-1 stimulation (ie, possible post-
translational modifications including phosphorylation, acetylation, methylation).
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Table 1: Proteins whose expression is consistently increased after 8 hour treatment with IGF-1.
Spot Number Protein Name NCBI gi # Fold Increase SC (%) Z-score MW; pI (theoretical) MW; pI (actual)
Adaptor Protein:
1 CASK interacting protein 1 161168996 3.8 ± 0.2 11 2.29 141.42/9.5 120/8.5
2 Wbscr1 protein 15928652 3.9 ± 0.4 41 1.93 25.22/7.8 27/7.5
Cell surface receptor:
3 Stabilin 1 26352640 4.0 ± 0.4 17 2.09 49.21/8.0 55/8.0
Cytoskeletal/Structural:
4 GRIP and coiled-coil domain-
containing protein 2
32469711 3.2 ± 0.1 12 1.75 195.40/5.1 170/5.8
5 Rho interacting protein 3 56205310 3.3 ± 0.1 12 1.27 115.70/6.0 140/6.5
6 Vimentin 55408 5.3 ± 0.6 23 1.93 53.72/5.1 55/5.6
DNA Binding protein:
7 RAD50 1575575 5.0 ± 0.4 14 1.59 154.61/6.5 80/7.8
Enzyme: Hydratase
8 Enolase (phosphopyruvate 
hydratase) (EC 4.2.1.11) alpha
109803 4.7 ± 0.3 29 1.90 47.45/6.4 50/5.7
Enzyme: IsomeraseP
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9 Triose-phosphate isomerase 1363194 3.8 ± 0.1 27 2.01 27.02/6.9 30/7.5
Enzyme: 
Sulphotransferase:
10 N-deacetylase/N-
sulfotransferase 4
11344505 3.7 ± 0.3 10 1.74 101.24/6.9 100/6.5
Extracellular matrix:
11 Collagen alpha-1(XVII) chain 41688459 3.5 ± 0.4 8 1.38 148.48/9.0 160/7.2
Heat shock protein 
(Chaperone):
12 Heat shock protein 8 42542422 3.3 ± 0.2 21 1.39 71.08/5.3 78/5.3
13 Heat shock protein A/p66 mot 34784211/5736598 4.1 ± 0.4 14 73.80/5.9 62/5.2
Phosphotransferase:
14 FLT-1 (Tyrosine-protein kinase 
receptor FLT)
2809069 3.1 ± 0.2 8 1.53 151.71/9.1 160/10
15 Ikbkb protein 22902306 3.6 ± 0.4 22 1.60 87.91/5.7 80/7.8
Reductase:
16 pyrroline-5-carboxylate 
reductase-like
119508439 4.1 ± 0.4 27 1.32 29.13/6.8 36/7.9
Table 1: Proteins whose expression is consistently increased after 8 hour treatment with IGF-1. (Continued)P
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Ribonuclease:
17 Plenty-of-prolines-101; 
POP101; SH3-philo-protein
3153821 5.6 ± 1.0 20 1.68 101.21/11.9 110/6.2
Transcription factor:
18 NFKB-repressing factor-
Transcription factor NRF
12861044 3.0 ± 0.1 13 1.49 77.71/9.1 33/4.5
Unclassified/Unknown 
function:
19 Cep290 26353954 4.1 ± 0.3 33 2.08 93.89/7.6 95/7.6
20 mKIAA0209 protein/dedicator 
of cytokinesis 2
50510415 3.2 ± 0.1 16 1.45 182.35/6.7 125/7.5
21 mKIAA1486 protein 81896693 3.0 ± 0.3 13 1.95 71.19/9.1 63/8.5
22 nasopharyngeal epithelium 
specific protein 1
3.4 ± 0.1 30 2.08 65.98/9.0 75/9.0
23 progesterone-induced blocking 
factor 1 isoform a
46852193 3.3 ± .03 21 1.73 89.88/5.9 90/6.8
Note 1: Protein classification is according to the Human Protein Reference Database http://www.hprd.org.
Note 2: SC%: Percentage of sequence coverage.
Note 3: Spot Number refers to the location of the individual proteins on 2D gels as shown in Figures 3–6. When a protein was identified in more than one Batch IEX fraction, it is marked 
multiple gels.
Note 4: Supplemental Table 2 contains all MALDI TOF data generated for each protein.
Note 5: Only proteins with probability score of 1.0e+000 were included in the table.
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Table 2: Proteins whose expression is consistently decreased after 8 hour treatment with IGF-1.
Spot Number Protein Name NCBI gi # Fold Decrease SC (%) Z-Score MW; pI (theoretical) MW; pI (actual)
Cell surface receptor:
24 Platelet-derived growth factor 
receptor, alpha precursor (PDGF-R-
alpha)
2506800 3.8 ± 0.3 11 1.30 123.68/5.0 125/4.8
Cytoskeletal protein:
24A cofilin 6680924 4.9 ± 0.1 37 2.01 18.55/8.5 25/5.6
DNA topoisomerase activity:
25 Topoisomerase (DNA) II beta 32451610 3.6 ± 0.2 11 1.82 182.80/8.7 140/8.0
GTPase activating protein:
26 Rac GTPase activating protein; 
GAB-associated CDC42
28569544 3.4 ± 0.3 8 1.62 191.74/6.6 180/7.0
27 Rho GDP-dissociation inhibitor 1 31982030 3.6 ± 0.2 34 2.30 23.41/5.1 30/5.4
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28 Heat shock protein 1 (chaperonin) 16741093 5.8 ± 0.2 18 1.46 59.02/5.5 60/5.7
Protein Phosphatase:
29 secreted embryonic phosphatase 16580151 4.1 ± 0.4 25 1.27 55.23/6.3 60/7.8
Structural constituent of 
ribosome:
30 Stmn1 protein 32449851 3.2 ± 0.3 32 1.60 17.26/5.7 18/7.6
Transcription factor:
31 myelin transcription factor 1-like 6679000 3.9 ± 0.1 20 2.05 137.62/4.8 140/5.2
32 zinc finger protein 100 50510803 4.7 ± 0.4 8 1.99 104.8/9.3 100/8.5
Transport/Cargo:
33 Sorting nexin 13 38614111 3.8 ± 0.2 6 1.13 111.54/6.2 120/7.0
Ubiquitin proteasome system 
protein:
Table 2: Proteins whose expression is consistently decreased after 8 hour treatment with IGF-1. (Continued)P
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34 ubiquitin fusion degradation 1 like 31981443 4.3 ± 0.1 22 1.83 34.75/6.0 29/6.4
35 Ubiquitin-conjugating enzyme E2 N 46577661 3.2 ± 0.1 24 2.22 17.14/6.1 18/6.5
Unclassified/Unknown function:
36 Mapkbp1 47124622 4.0 ± 0.1 9 1.11 164.70/6.3 60/7.5
37 Phosphatidylethanolamine-BP 1 1517864 3.2 ± 0.3 17 2.31 20.83/5.2 22/5.2
38 Stromal antigen 2 41940887 3.8 ± 0.1 21 1.66 135.13/5.2 190/6.2
39 Tpr 14329713 3.7 ± 0.2 18 1.40 139.30/5.3 110/5.3
Note 1: Protein classification is according to the Human Protein Reference Database http://www.hprd.org.
Note 2: SC%: Percentage of sequence coverage.
Note 3: Spot Number refers to the location of the individual proteins on 2D gels as shown in Figures 3–6. When a protein was identified in more than one Batch IEX fraction, it is marked 
multiple gels.
Note 4: Supplemental Table 2 contains all MALDI TOF data generated for each protein.
Note 5: Only proteins with probability score of 1.0e+000 were included in the table.
Table 2: Proteins whose expression is consistently decreased after 8 hour treatment with IGF-1. (Continued)Proteome Science 2009, 7:28 http://www.proteomesci.com/content/7/1/28
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mouse C2C12 myoblast cells in culture. For this analysis
we have developed an improved fractionation technique
to separate proteins into cytoplasmic, nuclear, and deter-
gent insoluble fractions and then to sub-fractionate the
largest population of soluble proteins by batch ion-
exchange chromatography into four separate elution
batches. The batch elution was followed by desalting and
protein concentration, thereby making the proteins ame-
nable to 2D electrophoresis. The present revised sub-frac-
tionation scheme has proven to be effective for increasing
the total number of visualized spots in subsequent 2D gel
analysis by 3-fold to over 3900. However, as expected
with any fractionation technique, multiple spots were
mapped to identical positions in different elutions from
the Q-Sepherose. When these ~650 spots were removed
from the analysis, the net increase in unique spots
observed from our fractionation protocol was increased
2.5-fold to over 3200. The loss of protein was minimal in
6 independent experiments using this procedure and our
data have not shown a major degree of selective protein
loss. Within the 200 mM elution fraction, we identified 23
proteins whose expression increased and 17 proteins
whose expression decreased suggesting IGF-1 signaling
regulated the transcription of many different genes.
In a parallel series of experiments, changes in the mRNA
expression profiles of C2C12 cells was analyzed to deter-
mine the effects of IGF-1 on regulation of gene expression.
The results of a thorough analysis of all of the microarray
data and the expression data did not reveal any strong cor-
relation between the two sets of data (R. Bhasker and T.
Friedmann, personal communication). The lack of corre-
lation between microarray and proteomic data has been
observed by other groups [18-21] and may be explained
by regulated translation, microRNAs, or alterations/regu-
lation of proteosomal or other degradation.
To test the degree of the sample variability that inevitably
arises from different cell preparations, we routinely ana-
lyzed triplicate gels from three different experiments of
IGF-1 stimulation of C2C12 cells at each of the 5 time
points. Overall, the levels and positions of 90% of the
proteins visualized at a single time point (nine different
2D gels) did not change after IGF-1 treatment. Of the 90%
Expression of Rho-GDI, Cofilin, PDGF receptor α, and MAPKBP-1 decreases upon IGF-1 stimulation of C2C12 cells Figure 4
Expression of Rho-GDI, Cofilin, PDGF receptor α, and MAPKBP-1 decreases upon IGF-1 stimulation of C2C12 
cells. A) Triplicate samples from three different C2C12 cell preparations were stimulated with IGF-1 (100 ng/ml) for up to 8 
hours, fractionated using batch ion-exchange, separated by 2D electrophoresis, and proteins were detected with silver stain. 
The protein highlighted by a yellow square (Rho-GDI, Cofilin, PDGF receptor α, and MAPKBP-1) decrease in expression after 
IGF-1 treatment. PDQuest analysis indicates a quantitative change in the protein based on total quantitation of the entire gel. 
B) Western blot analysis confirms the sustained decrease in protein expression for Rho-GDI, cofilin, and the PDGF receptor.
A. B.Proteome Science 2009, 7:28 http://www.proteomesci.com/content/7/1/28
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of proteins whose expression remained constant at a sin-
gle time point, the variability between spots from tripli-
cate samples at different times of IGF-1 treatment was less
than 8% as determined using the matching algorithm of
PDQuest (data not shown). Taken together, these data
suggest that expression of most proteins does not dramat-
ically change upon IGF-1 treatment. It is common in most
batch ion-exchange methods for high-abundance proteins
to be found in multiple elution fractions protein separa-
tion. In our studies, approximately 18% of the proteins
observed were seen in multiple gels representing different
fractionation pools and not surprisingly, mass spectro-
metric methods revealed that most such proteins were
high abundance proteins such as actin and multiple iso-
forms of heat shock proteins (data not shown). In 2D
electrophoresis and computer aided analytic protocols,
elution of the same landmark protein into multiple frac-
tions helps to align very refined 2D maps which can be
subsequently be used to track low abundance proteins
and post-translational modifications.
A major concern regarding 2D-gel analysis of proteins
under these conditions is the likelihood that some appar-
ently single spots will in fact contain different proteins
with similar electrophoretic and charge properties. We
have been able to obviate that possibility to at least some
extent by using the landmarks described in Table 1 to
identify distinct proteins the run in similar positions on
2D gels but that elute at different salt concentrations
(Additional File 8). Nevertheless, the protein overlap
Expression of Rad50, enolase, IκB kinase b, and Hsp70 increases upon IGF-1 stimulation of C2C12 cells Figure 5
Expression of Rad50, enolase, IκB kinase b, and Hsp70 increases upon IGF-1 stimulation of C2C12 cells. A) Trip-
licate samples from three different C2C12 cell preparations were stimulated with IGF-1 (100 ng/ml) for up to 8 hours, fraction-
ated using batch ion-exchange, separated by 2D electrophoresis, and proteins were detected with silver stain. The protein 
highlighted by a yellow square (Rad50, enolase, IκB kinase b, and Hsp70) increase in expression after IGF-1 treatment. 
PDQuest analysis indicates a quantitative change in the protein based on total quantitation of the entire gel. B) Western blot 
analysis confirms the sustained increase in protein expression for Rad50, enolase, IκB kinase b, and Hsp70. C) RAD50 accumu-
lates in the cytosolic fraction of IGF-1 stimulated C2C12 cells.
A. B.
C.Proteome Science 2009, 7:28 http://www.proteomesci.com/content/7/1/28
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problem was frequently observed in these studies and
remains a serious problem in proteomic studies of all
kinds, making it likely that many changes in stimulus-
induced protein expression may be masked during analy-
sis. Although fraction of complicated samples partially
resolves this issue, more advanced separation techniques
must be developed to completely address this issue.
The present studies focus on the effect of IGF-1 on changes
in expression of fractionated cytosolic proteins. A compli-
cating factor in these studies is that proteins often redis-
tribute from the cytosol to various other intracellular
locations including organelles (nucleus, mitochondria),
membranes, and cavelolae. Fractionation of these sub-cel-
lular populations of proteins may result in an erroneous
identification of a change in expression when in fact the
total levels of protein do not change. This is demonstrated
in Figure 2 (second panel; Erk2) that redistributed to the
nucleus (data not shown) and RAD50 that accumulates in
the cytosol (Figure 5C). Whether these changes observed
in protein localization represent responses to IGF-1 or to
cell processing remains to be determined. However, these
findings emphasize the need for a balanced yet rigorous
analytical biochemical analysis of candidate protein
expression from total cell lysates and multiple fractions.
Analysis of total, nuclear, and cytosolic fractions of eno-
lase, IκBKb, PDGF receptor, cofilin, and Rho-GDI identi-
fied these proteins as cytosolic and were not found
appreciably in the nucleus. Therefore, the change in pro-
tein expression is likely due to a direct effect of IGF-1 (data
not shown). However, significant amounts of Hsp70 were
found in both the nuclear and cytosolic fractions of
C2C12 cells. The amount of nuclear Hsp70 did not appre-
ciably decrease as cytosolic levels increased, indicating
that changes in expression of this protein also respond to
IGF-1. It remains to be determined whether changes in
expression of the other proteins identified in this study
can be attributed to alterations in subcellular distribution.
The present identification of up- or down-regulated pro-
teins emphasizes the proteins that showed a consistent
temporal increase or decrease in expression over the entire
time course of these studies. Attempts to determine
whether any of these proteins are directly linked to IGF-1
signaling or part of a larger protein/signal transduction
network did not yield any plausible links, suggesting pro-
teins whose expression changes in response to IGF-1
remain to be identified. The proteins identified only rep-
resent a portion of the changes that we observed in the
IGF-1-treated cells. The present report does not include a
complete analysis of the proteins that demonstrate com-
plex, multiphasic changes in absolute amount or in their
pI or apparent electrophoretic mobility (Figure 3A, lower
panel). Nevertheless, we have identified a number of pro-
teins that are increased robustly to IGF-1 at early time
points (1–2 hours) but that then are subsequently
decreased in the later time points and have returned to
basal levels by 8 and 24 hours (see Figure 6). These pro-
teins may represent attractive candidates for critical sign-
aling molecules that play important roles in the action of
IGF-1. Conversely, other proteins show strong but appar-
ently delayed down-regulation by IGF-1. It remains to be
determined if these changes are direct effects of IGF-1 or
are the result of secondary metabolites, are cell death or
loss or other mechanisms. Mass spectrometry analysis of
a number of these proteins indicates that they represent
modified variants of the same protein (data not shown).
Our future studies will be aimed at determining to what
Triplicate samples from three different C2C12 cell preparations were stimulated with IGF-1 (100 ng/ml) for up to 8 hours,  fractionated using batch ion-exchange, separated by 2D electrophoresis, and proteins were detected with silver stain Figure 6
Triplicate samples from three different C2C12 cell preparations were stimulated with IGF-1 (100 ng/ml) for up 
to 8 hours, fractionated using batch ion-exchange, separated by 2D electrophoresis, and proteins were 
detected with silver stain. The protein highlighted by a yellow square (eIF-4H) rapidly increases in expression after 1 hour 
IGF-1 treatment, but then decreases at 4 and 8 hours.
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extent these variations represent splice variants or arise
from post-translational protein modifications. Alterations
to the focusing patterns on 2D gels at specific time points
during IGF-1 treatment may help identify changes in pro-
tein expression, subcellular localization, and/or signaling.
Two other laboratories have examined the proteome of
C2C12 cells, one using a 2D electrophoresis/MALDI MS
approach [22], the other using a LC MS/MS approach
[23]. The focus of both studies was to identify proteins in
C2C12 cells that have regulated expression during muscle
development. In the first study, Tannu et al. identified the
positional location of proteins in 2D gels whose expres-
sion changed during myogenic differentiation. Given the
different experimental conditions and focus on landmark
proteins in the current study, it is not surprising that many
of the 106 proteins identified by Tannu were not identi-
fied here. In the second study, Kislinger et al. used a LC
MS/MS approach to identify proteins that change in
expression upon C2C12 differentiation [23]. Comparing
proteins identified in the Tannu and Kislinger studies (see
Kinlinger Supplemental Data, p.940) to our study finds
that actin, 60 kD heat shock protein, and mitochondrial
ATP synthase levels remain constant. Abundant proteins
often identified in many studies and cell types, including
actin, myosin heavy/light chain, protein disulfide isomer-
ases, glucose regulated protein, and ATP synthase subu-
nits were also identified in all three studies. Interestingly,
the expression levels of these proteins remained constant
during the 8 hour time course in our studies, but all
increased during the 5 day differentiation protocol used
by Tannu and Kislinger. Additionally, in our studies, we
identified vimentin, enolase, and heat shock protein 8 as
proteins whose expression increased during an 8 hour
treatment with IGF-1. The same proteins identified by
Tannu, decreased (vimentin) or remained the same dur-
ing myogenic differentiation. Whether these differences
represent changes that are specifically initiated during dif-
ferentiation or during IGF-1 stimulation remains to be
determined.
In their previous studies, Tannu and Kislinger specifically
tracked individual proteins that are up- or down-regulated
by IGF-1 revealed a mixture of enzyme classes [22,23]. As
in our present study, the changes in the levels and proper-
ties of these proteins may be related to both cell culture
conditions and post-translational modifications. Of par-
ticular interest are the identification in this study of the
up-regulation of PDGF by IGF-1 and the identification in
another study of the regulation of PDGF expression by
insulin in C2C12 cells [24]. Because of the similarities in
signal responses to insulin and IGF-1, it seems possible
that this growth factor is an important target for IGF-1
action in these cells. In addition, we are particularly inter-
ested to examine further the changes in the levels of sev-
eral cytoskeletal regulators such as Rho-GDI and cofilin, a
protein associated with the cytoskeleton that binds actin
and reversibly controls polymerization and depolymeri-
zation in a pH-sensitive manner. The ability of cofilin to
regulate actin polymerization is known to be regulated by
reversible phosphorylation, suggesting this protein may
also be a candidate target protein for IGF-1 action.
Traditional approaches to detection and identification of
performance-enhancing substances and methods have
generally focused on assays for the performance-enhanc-
ing substances themselves. However, a potentially more
powerful approach may involve the identification of qual-
itative and quantitative drug-induced signature changes in
gene and protein expression and in the metabolome of
treated tissues. Development of a panel of such biomark-
ers that collectively can be shown to represent a reliable
signature for exposure to exgenous IGF-1 or other agents
such as a variety of growth hormones, steroids, etc., could
represent a useful addition to the anti-doping effort.
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Additional file 1
Silver stain of cytosolic, membrane, and detergent insoluble proteins 
before and after desalting and concentration. The data provided repre-
sent the fidelity of recovery of proteins after desalting and concentrating.
Click here for file
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Additional file 2
Landmark proteins identified in fractionated C2C12 cells. The data 
provided represent MALDI-TOF information from each protein identified 
in these studies.
Click here for file
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Additional file 3
Silver stain of a representative 2D gel from the unbound elution of 
unstimulated C2C12 cells. The data provided show the positional loca-
tion of proteins identified by MALDI TOF from the unbound elution of 
unstimulated C2C12 cells.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
5956-7-28-S3.pdf]
Additional file 4
Silver stain of a representative 2D gel from the 200 mM elution of 
unstimulated C2C12 cells. The data provided show the positional loca-
tion of proteins identified by MALDI TOF from the 200 mM elution of 
unstimulated C2C12 cells.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
5956-7-28-S4.pdf]
Additional file 5
Silver stain of a representative 2D gel from the 400 mM elution of 
unstimulated C2C12 cells. The data provided show the positional loca-
tion of proteins identified by MALDI TOF from the 400 mM elution of 
unstimulated C2C12 cells.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
5956-7-28-S5.pdf]
Additional file 6
Silver stain of a representative 2D gel from the 650 mM elution of 
unstimulated C2C12 cells. The data provided show the positional loca-
tion of proteins identified by MALDI TOF from the 650 mM elution of 
unstimulated C2C12 cells.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
5956-7-28-S6.pdf]
Additional file 7
MALDI-TOF data from each protein identified in these studies. The 
data provided represents all MALDI-TOF information from each protein 
identified in these studies.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
5956-7-28-S7.pdf]
Additional file 8
BIEX helps resolve cytosolic proteins with similar isoelectric points and 
apparent molecular weight. The data provided show that proteins that 
focus at the same molecular weight and isoelectric point can be resolved 
after batch ion exchange chromatography.
Click here for file
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